Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more
Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 05, 2019 issue